Our technology is using AI to identify and minimize the side effect of immunotherapies. Our AI algorithm is trained on multiple examples of protein interactions that allows it to detect unwanted/harmful interactions between the drug and healthy cells. This can increase the accuracy of testing by 16 times and speed by 30 times. We provide a software that predicts off-target activity during development that leads to safe immunotherapies. We license our software to biotech companies...
Our technology is using AI to identify and minimize the side effect of immunotherapies. Our AI algorithm is trained on multiple examples of protein interactions that allows it to detect unwanted/harmful interactions between the drug and healthy cells. This can increase the accuracy of testing by 16 times and speed by 30 times. We provide a software that predicts off-target activity during development that leads to safe immunotherapies. We license our software to biotech companies
More information

Employees

Elzbieta Maria Piatkowska
Admin
Elzbieta Maria Piatkowska CEO Biochemist with 15 years od expertise in the analysis of cancer and autoimmune protein networks and experience in department management.